McDonald Stephen P, Collins John F, Rumpsfeld Markus, Johnson David W
ANZDATA Registry, Adelaide, South Australia.
Perit Dial Int. 2004 Jul-Aug;24(4):340-6.
The aim of the present investigation was to examine the association between body mass index (BMI) and peritonitis rates among incident peritoneal dialysis (PD) patients in a large cohort with long-term follow-up.
Retrospective observational cohort study of the Australian and New Zealand PD patient population.
Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry.
The study included all incident adult patients (n = 10 709) who received PD in Australia and New Zealand in the 12-year period between 1 April 1991 and 31 March 2003. Patients were classified as obese (BMI > or = 30 kg/m2), overweight (BMI 25.0 - 29.9 kg/m2), normal weight (20 - 24.9 kg/m2), or underweight (< 20 kg/m2).
Time to first peritonitis and episodes of peritonitis per patient-year were recorded over the 12-year period.
Higher BMI was associated with a shorter time to first peritonitis episode, independent of other risk factors [hazard ratio 1.08 for each 5-kg/m2 increase in BMI, 95% confidence interval (CI) 1.04 - 1.12, p < 0.001]. When peritonitis outcomes were analyzed as episodes of peritonitis per patient-year, these rates were significantly higher among patients with higher BMI: underweight 0.69 episodes/year (95% CI 0.66 - 0.73), normal weight 0.79 (95% CI 0.77 - 0.81), overweight 0.88 (95% CI 0.85 - 0.90), obese 1.06 (95% CI 1.02 - 1.09). Coronary artery disease and chronic lung disease were associated with both shorter time to first peritonitis and higher peritonitis rates, independently of these other factors. There was also a "vintage effect," with lower peritonitis rates seen among people who commenced dialysis in more recent years.
Higher BMI at the commencement of renal replacement therapy is a significant risk factor for peritonitis. The mechanisms for this remain undefined.
本研究旨在探讨在一个长期随访的大型队列中,新发腹膜透析(PD)患者的体重指数(BMI)与腹膜炎发生率之间的关联。
对澳大利亚和新西兰PD患者群体进行回顾性观察队列研究。
澳大利亚和新西兰透析与移植(ANZDATA)登记处。
该研究纳入了1991年4月1日至2003年3月31日这12年间在澳大利亚和新西兰接受PD治疗的所有成年新发患者(n = 10709)。患者被分为肥胖(BMI≥30 kg/m²)、超重(BMI 25.0 - 29.9 kg/m²)、正常体重(20 - 24.9 kg/m²)或体重过轻(<20 kg/m²)。
记录12年间首次发生腹膜炎的时间以及每名患者每年的腹膜炎发作次数。
较高的BMI与首次发生腹膜炎发作的时间较短相关,且独立于其他风险因素[BMI每增加5 kg/m²,风险比为1.08,95%置信区间(CI)1.04 - 1.12,p < 0.001]。当将腹膜炎结局分析为每名患者每年的腹膜炎发作次数时,BMI较高的患者中这些发生率显著更高:体重过轻患者为0.69次/年(95% CI 0.66 - 0.73),正常体重患者为0.79次/年(95% CI 0.77 - 0.81),超重患者为0.88次/年(95% CI 0.85 - 0.90),肥胖患者为1.06次/年(95% CI 1.02 - 1.09)。冠状动脉疾病和慢性肺病与首次发生腹膜炎的时间较短以及腹膜炎发生率较高均相关,且独立于这些其他因素。还存在一种“年代效应”,即近年来开始透析的人群中腹膜炎发生率较低。
肾脏替代治疗开始时较高的BMI是腹膜炎的一个重要危险因素。其机制尚不清楚。